| Literature DB >> 36015660 |
Alejandro Aragón-Gutiérrez1, Raquel Heras-Mozos2, Antonio Montesinos1, Miriam Gallur1, Daniel López3, Rafael Gavara2, Pilar Hernández-Muñoz2.
Abstract
Antimicrobial packaging has emerged as an efficient technology to improve the stability of food products. In this study, new formulations based on ethylene vinyl alcohol (EVOH) copolymer were developed by incorporating the volatile methyl anthranilate (MA) at different concentrations as antifungal compound to obtain active films for food packaging. To this end, a twin-screw extruder with a specifically designed screw configuration was employed to produce films at pilot scale. The quantification analyses of MA in the films showed a high retention capacity. Then, the morphological, optical, thermal, mechanical and water vapour barrier performance, as well as the antifungal activity in vitro of the active films, were evaluated. The presence of MA did not affect the transparency or the thermal stability of EVOH-based films, but decreased the glass transition temperature of the copolymer, indicating a plasticizing effect, which was confirmed by an increase in the elongation at break values of the films. Because of the additive-induced plasticization over EVOH, the water vapour permeability slightly increased at 33% and 75% relative humidity values. Finally, the evaluation of the antifungal activity in vitro of the active films containing methyl anthranilate showed a great effectiveness against P. expansum and B. cinerea, demonstrating the potential applicability of the developed films for active food packaging.Entities:
Keywords: EVOH copolymer; active packaging; antifungal activity; film properties; melt-extrusion; methyl anthranilate
Year: 2022 PMID: 36015660 PMCID: PMC9416094 DOI: 10.3390/polym14163405
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Figure 1Schematic representation of the film-extrusion process.
Figure 2FT-IR spectra of EVOH-MA samples.
Film formulations and retention capacity of methyl anthranilate quantified by GC-MS analysis.
| Formulation | Code | Methyl Anthranilate (wt.%) | Retention Capacity (%) |
|---|---|---|---|
| Neat EVOH | EVOH | n.d. | - |
| EVOH + 3 wt.% methyl anthranilate | EVOH-MA3 | 2.52 ± 0.36 | 84 |
| EVOH + 5 wt.% methyl anthranilate | EVOH-MA5 | 3.84 ± 0.20 | 76 |
| EVOH + 8 wt.% methyl anthranilate | EVOH-MA8 | 6.42 ± 0.17 | 80 |
Figure 3SEM micrographs of sample surfaces and cross sections (×100 and ×500, respectively.).
Figure 4DSC thermograms during (a) first heating, (b) cooling and (c) second heating scan.
DSC and TGA parameters.
| First Heating Scan | Cooling Scan | Second Heating Scan | TGA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Formulation | Tg | Tm | ∆Hm | χc | Tc | ∆Hc | Tg | Tm | ∆Hm | χc | ΔW0–200 | TmaxI
| TmaxII
|
| EVOH | 52 | 169 | 68.8 | 31.5 | 143 | 61.8 | 54 | 167 | 66.5 | 30.5 | 0.2 | 399 | 459 |
| EVOH-MA3 | 43 | 165 | 55.7 | 26.4 | 141 | 56.8 | 44 | 165 | 65.3 | 30.9 | 2.25 | 395 | 445 |
| EVOH-MA5 | 40 | 164 | 57.4 | 27.3 | 139 | 53.9 | 42 | 163 | 56.9 | 27.4 | 4.33 | 389 | 452 |
| EVOH-MA8 | 37 | 162 | 50.9 | 25.4 | 138 | 52.9 | 39 | 162 | 52.7 | 26.3 | 6.12 | 392 | 451 |
Figure 5TGA and DTG curves for EVOH-based samples.
Figure 6Representative stress-strain curves of EVOH-based films.
Mechanical properties and water vapor permeability values of EVOH-based films.
| Reference | E (GPa) | Stress @ Yield (MPa) | Stress @ Break (MPa) | Elongation @ Break (%) | WVP·1015 (kg·m/m2 s Pa) | |
|---|---|---|---|---|---|---|
| 33% RH | 75% RH | |||||
| EVOH | 2.5 ± 0.2 a | 46 ± 3 a | 62 ± 5 a | 174 ± 16 a | 0.12 ± 0.01 | 1.08 ± 0.02 |
| EVOH-MA3 | 2.4 ± 0.1 a | 41 ± 4 a | 54 ± 7 b | 224 ± 18 b | 0.11 ± 0.01 | 0.99 ± 0.04 |
| EVOH-MA5 | 2.3 ± 0.2 a | 41 ± 4 a | 46 ± 10 b,c | 260 ± 21 c | 0.15 ± 0.02 | 1.14 ± 0.02 |
| EVOH-MA8 | 2.2 ± 0.1 a | 40 ± 5 a | 43 ± 8 c | 253 ± 12 c | 0.18 ± 0.01 | 1.38 ± 0.06 |
a–c: different superscript within the same column indicates significant different between film formulations (Turkey test, p < 0.05).
Thickness, colour parameters and transparency of extruded EVOH-based films.
| Reference | Thickness (µm) | L | a | b | ΔE | T (A600/t) |
|---|---|---|---|---|---|---|
| EVOH | 50 ± 2 | 93.1 | 0.04 | −0.49 | - | 0.89 ± 0.01 |
| EVOH-MA3 | 53 ± 3 | 92.6 ± 0.1 | −0.59 ± 0.02 | 3.6 ± 0.04 | 4.1 ± 0.1 | 0.88 ± 0.01 |
| EVOH-MA5 | 55 ± 3 | 92.5 ± 0.1 | −0.81 ± 0.01 | 4.12 ± 0.02 | 4.7 ± 0.2 | 0.84 ± 0.01 |
| EVOH-MA8 | 54 ± 4 | 92.6 ± 0.1 | −0.78 ± 0.05 | 4.31 ± 0.04 | 4.9 ± 0.1 | 0.77 ± 0.02 |
Figure 7Methyl anthranilate release from EVOH based films after 10 days influenced by relative humidity (33, 75 and >95%).
Antimicrobial effectiveness of methyl anthranilate against P. expansum and B. cinerea expressed as MIC and MFC (μL/plate) after 10 days of incubation at 26 °C.
| MIC (μL/plate) | MFC (μL/plate) | Control | MIC | MFC | |
|---|---|---|---|---|---|
|
| 2.5 | 20 |
| ||
|
| 1 | 5 |
| ||
Figure 8Effectiveness of EVOH incorporated with methyl anthranilate against P. expansum and B. cinerea expressed as inhibition of fungal colony (%) during 10 days of at 26 °C.
Figure 9Visual aspect of fungal colony of P. expansum and B. cinerea co-incubated with cast extruded EVOH films incorporated with methyl anthranilate after 7 days at 26 °C.